MedPath

Financial and Insurance Assistance- Oncology Financial and Legal Navigation Program

Not Applicable
Completed
Conditions
Financial Stress
Pediatric Cancer
Interventions
Other: FINassist Patient
Other: FINassist Caregiver
Registration Number
NCT05876325
Lead Sponsor
Jean Edward
Brief Summary

The overall objective of this study was to develop and evaluate FINassist (Financial and Insurance Navigation Assistance), a patient-centered, interdisciplinary team-based oncology financial and legal navigation program. The program leverages Medical Legal Partnerships to enhance cost of care conversations with pediatric oncology patients and caregivers. FINassist optimizes the team-based care model by integrating clinicians, social workers, financial navigators, and legal advocates who work in tandem to enhance cost of care conversations with patients and caregivers, identify and intervene on patient socio-legal needs, and advocate for system-level changes.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
61
Inclusion Criteria
  • Caregivers of patients who have any cancer or hematologic disorder diagnosis at the DanceBlue Pediatric Hematology/oncology clinic at Kentucky Children's hospital
  • Patients with childhood cancers and/or hematologic disorders at the DanceBlue Pediatric Hematology/oncology clinic at Kentucky Children's hospital
  • 18 years and older
Exclusion Criteria
  • Unable to provide consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Financial Navigation and Insurance Assistance (FINassist)FINassist PatientFINassist is a comprehensive oncology financial and legal navigation program in oncology care
Financial Navigation and Insurance Assistance (FINassist)FINassist CaregiverFINassist is a comprehensive oncology financial and legal navigation program in oncology care
Primary Outcome Measures
NameTimeMethod
Change in Total Financial ToxicityBaseline and post intervention, approximately 12 weeks

Measured using the COmprehensive Score for financial Toxicity (COST) tool, a measure that describes the financial distress experienced by cancer patients. Scores range from 0-44 with a higher score representing better financial well-being.

Change in Participant Quality of Life (Depression)Baseline and post intervention, approximately 12 weeks

Measured using the 6-item Patient-Reported Outcomes Measurement Information System PROMIS® Depression Short Form. Scores range from 6 to 30. Higher scores indicate more of the construct being measured.

Number of participants enrolled12 months

Feasibility was defined as 60% or higher enrolled participant retention and resolution of financial or legal issue (based on existing oncology financial navigation studies)

Change in PROMIS Parent Proxy Pain InterferenceBaseline and post intervention, approximately 12 weeks

used to measure child QOL (when applicable), with summary scores for proxy measures of global health, pain interference, and fatigue Consequences of pain on relevant aspects of one's life. This includes the extent to which pain hinders engagement with social, cognitive, emotional, physical, and recreational activities.

FINassist Adherencethrough issue resolution up to 12 months

Adherence is defined by the percentage of participants that maintain communication with the team and provide documents necessary for issue resolution

Resolution of Socio-legal Issue12 months

Number of participants that resolved a legal or financial case as a result of FINassist

Change in PROMIS Parent Proxy Global HealthBaseline and post intervention, approximately 12 weeks

used to measure child QOL (when applicable), with summary scores for proxy measures of global health, pain interference, and fatigue Overall evaluation of physical, mental health, and social health.

FINassist Acceptability assessed by 5-item surveyPost intervention at 12 months

Acceptability is measured using a 5 item post-intervention survey of relevance, helpfulness, convenience, recommendation to others, and value. Ratings on a scale from 0 to 10 where a higher score means greater acceptability

Change in Participant Quality of Life (physical and mental)Baseline and post intervention, approximately 12 weeks

Measured using the 10-item PROMIS® (Patient-Reported Outcomes Measurement Information System) Parent Proxy Global Health scale. A 7-item summary assessment of a child's self-reported health with higher scores representing better quality of life. Values range from 7-35, with higher scores representing better health.

Change in Patient-Provider TrustBaseline and post intervention, approximately 12 weeks

Measured using the the Health Care Relationship (HCR) Trust Scale. The HCR-Trust scale is scored from 0 to 4 with a maximum score of 52. Higher scores represent more trust in healthcare providers

FINassist Retentionthrough study completion up to 12 months

percentage of participants that complete both pre and post-intervention surveys

Change in Participant Quality of Life (Anxiety)Baseline and post intervention, approximately 12 weeks

Measured using the 4-item Patient-Reported Outcomes Measurement Information System PROMIS® Anxiety short form. Scores range from 4 to 20. Higher scores indicate more of the construct being measured.

Change in PROMIS Parent Proxy FatigueBaseline and post intervention, approximately 12 weeks

used to measure child QOL (when applicable), with summary scores for proxy measures of global health, pain interference, and fatigue Range of symptoms, from mild subjective feelings of tiredness to an overwhelming, debilitating, and sustained sense of exhaustion.

Secondary Outcome Measures
NameTimeMethod
Number of Participants Receiving Financial Benefit12 months

financial benefit defined as economic hardship avoided or decreased public/government income

Trial Locations

Locations (1)

University of Kentucky DanceBlue Pediatric Hematology/oncology clinic

🇺🇸

Lexington, Kentucky, United States

© Copyright 2025. All Rights Reserved by MedPath